nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—Irinotecan—hematologic cancer	0.0475	0.107	CbGbCtD
Galantamine—BCHE—Triamcinolone—hematologic cancer	0.0378	0.0849	CbGbCtD
Galantamine—BCHE—Irinotecan—hematologic cancer	0.0286	0.0644	CbGbCtD
Galantamine—BCHE—Cisplatin—hematologic cancer	0.0233	0.0525	CbGbCtD
Galantamine—CYP2D6—Lomustine—hematologic cancer	0.0227	0.051	CbGbCtD
Galantamine—CYP2D6—Idarubicin—hematologic cancer	0.0202	0.0455	CbGbCtD
Galantamine—CYP2D6—Hydroxyurea—hematologic cancer	0.0172	0.0387	CbGbCtD
Galantamine—CHRFAM7A—ovarian follicle—hematologic cancer	0.0167	0.156	CbGeAlD
Galantamine—CYP3A4—Bexarotene—hematologic cancer	0.0155	0.0349	CbGbCtD
Galantamine—CYP2D6—Bortezomib—hematologic cancer	0.015	0.0336	CbGbCtD
Galantamine—CYP3A4—Lomustine—hematologic cancer	0.0144	0.0324	CbGbCtD
Galantamine—CYP3A4—Busulfan—hematologic cancer	0.0144	0.0324	CbGbCtD
Galantamine—CHRNA7—ovarian follicle—hematologic cancer	0.0135	0.126	CbGeAlD
Galantamine—CYP3A4—Thiotepa—hematologic cancer	0.0129	0.0289	CbGbCtD
Galantamine—CYP2D6—Imatinib—hematologic cancer	0.011	0.0246	CbGbCtD
Galantamine—CYP3A4—Methoxsalen—hematologic cancer	0.01	0.0225	CbGbCtD
Galantamine—CYP2D6—Nilotinib—hematologic cancer	0.00995	0.0224	CbGbCtD
Galantamine—CYP2D6—Vinorelbine—hematologic cancer	0.00987	0.0222	CbGbCtD
Galantamine—CYP3A4—Bortezomib—hematologic cancer	0.00951	0.0214	CbGbCtD
Galantamine—CYP3A4—Daunorubicin—hematologic cancer	0.00909	0.0205	CbGbCtD
Galantamine—CYP3A4—Cytarabine—hematologic cancer	0.00802	0.018	CbGbCtD
Galantamine—CYP3A4—Teniposide—hematologic cancer	0.0079	0.0178	CbGbCtD
Galantamine—CYP3A4—Ifosfamide—hematologic cancer	0.00729	0.0164	CbGbCtD
Galantamine—CYP3A4—Imatinib—hematologic cancer	0.00697	0.0157	CbGbCtD
Galantamine—CYP3A4—Ruxolitinib—hematologic cancer	0.00656	0.0148	CbGbCtD
Galantamine—CYP3A4—Nilotinib—hematologic cancer	0.00633	0.0142	CbGbCtD
Galantamine—CYP3A4—Vinorelbine—hematologic cancer	0.00628	0.0141	CbGbCtD
Galantamine—CYP2D6—Vinblastine—hematologic cancer	0.00608	0.0137	CbGbCtD
Galantamine—CYP3A4—Triamcinolone—hematologic cancer	0.00574	0.0129	CbGbCtD
Galantamine—CHRNE—blood—hematologic cancer	0.0056	0.0522	CbGeAlD
Galantamine—CYP3A4—Dasatinib—hematologic cancer	0.00559	0.0126	CbGbCtD
Galantamine—CYP3A4—Mitoxantrone—hematologic cancer	0.00553	0.0124	CbGbCtD
Galantamine—CYP3A4—Betamethasone—hematologic cancer	0.00493	0.0111	CbGbCtD
Galantamine—CYP3A4—Prednisolone—hematologic cancer	0.00486	0.0109	CbGbCtD
Galantamine—CHRNE—testis—hematologic cancer	0.00463	0.0432	CbGeAlD
Galantamine—CYP3A4—Prednisone—hematologic cancer	0.00459	0.0103	CbGbCtD
Galantamine—CYP2D6—Dexamethasone—hematologic cancer	0.00451	0.0101	CbGbCtD
Galantamine—CYP3A4—Irinotecan—hematologic cancer	0.00435	0.00979	CbGbCtD
Galantamine—CYP3A4—Vinblastine—hematologic cancer	0.00387	0.0087	CbGbCtD
Galantamine—CYP3A4—Vincristine—hematologic cancer	0.0038	0.00856	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—hematologic cancer	0.00374	0.00841	CbGbCtD
Galantamine—CHRNA10—hematopoietic system—hematologic cancer	0.00358	0.0334	CbGeAlD
Galantamine—CYP3A4—Etoposide—hematologic cancer	0.00348	0.00784	CbGbCtD
Galantamine—CHRNA5—testis—hematologic cancer	0.00324	0.0302	CbGeAlD
Galantamine—CYP3A4—Dexamethasone—hematologic cancer	0.00287	0.00645	CbGbCtD
Galantamine—CHRNG—blood—hematologic cancer	0.0028	0.0261	CbGeAlD
Galantamine—CHRNA1—hematopoietic system—hematologic cancer	0.00279	0.0261	CbGeAlD
Galantamine—CHRNG—bone marrow—hematologic cancer	0.00271	0.0253	CbGeAlD
Galantamine—CHRNA3—hematopoietic system—hematologic cancer	0.00249	0.0233	CbGeAlD
Galantamine—CHRNG—lung—hematologic cancer	0.00245	0.0229	CbGeAlD
Galantamine—CYP3A4—Doxorubicin—hematologic cancer	0.00238	0.00535	CbGbCtD
Galantamine—CHRNA10—blood—hematologic cancer	0.00237	0.0221	CbGeAlD
Galantamine—CHRNA5—lymph node—hematologic cancer	0.00235	0.0219	CbGeAlD
Galantamine—CHRNB4—testis—hematologic cancer	0.00223	0.0208	CbGeAlD
Galantamine—CHRFAM7A—hematopoietic system—hematologic cancer	0.00202	0.0188	CbGeAlD
Galantamine—CHRNA10—testis—hematologic cancer	0.00196	0.0183	CbGeAlD
Galantamine—CHRND—lung—hematologic cancer	0.00194	0.0182	CbGeAlD
Galantamine—CHRNB2—blood—hematologic cancer	0.0017	0.0159	CbGeAlD
Galantamine—CHRNB2—bone marrow—hematologic cancer	0.00165	0.0154	CbGeAlD
Galantamine—CHRNA7—hematopoietic system—hematologic cancer	0.00163	0.0152	CbGeAlD
Galantamine—CHRNA4—hematopoietic system—hematologic cancer	0.00161	0.015	CbGeAlD
Galantamine—CHRNA2—blood—hematologic cancer	0.00154	0.0143	CbGeAlD
Galantamine—CHRNB2—lung—hematologic cancer	0.00149	0.0139	CbGeAlD
Galantamine—CHRNA3—lung—hematologic cancer	0.00145	0.0135	CbGeAlD
Galantamine—CHRNB1—blood—hematologic cancer	0.00143	0.0133	CbGeAlD
Galantamine—CHRNA10—lymph node—hematologic cancer	0.00142	0.0133	CbGeAlD
Galantamine—CHRNB2—testis—hematologic cancer	0.00141	0.0132	CbGeAlD
Galantamine—CHRNA3—testis—hematologic cancer	0.00137	0.0128	CbGeAlD
Galantamine—CHRFAM7A—blood—hematologic cancer	0.00134	0.0125	CbGeAlD
Galantamine—CHRNB1—testis—hematologic cancer	0.00118	0.011	CbGeAlD
Galantamine—CHRFAM7A—testis—hematologic cancer	0.00111	0.0103	CbGeAlD
Galantamine—CHRNA7—blood—hematologic cancer	0.00108	0.0101	CbGeAlD
Galantamine—ACHE—testis—hematologic cancer	0.00103	0.00957	CbGeAlD
Galantamine—CHRNB2—lymph node—hematologic cancer	0.00102	0.00954	CbGeAlD
Galantamine—CHRNA3—lymph node—hematologic cancer	0.000991	0.00925	CbGeAlD
Galantamine—CHRNA4—lung—hematologic cancer	0.000933	0.00871	CbGeAlD
Galantamine—BCHE—hematopoietic system—hematologic cancer	0.000919	0.00858	CbGeAlD
Galantamine—CHRNA7—testis—hematologic cancer	0.000893	0.00833	CbGeAlD
Galantamine—CHRNB1—lymph node—hematologic cancer	0.000857	0.008	CbGeAlD
Galantamine—ACHE—lymph node—hematologic cancer	0.000743	0.00694	CbGeAlD
Galantamine—Morphine—UGT1A1—hematologic cancer	0.000661	0.449	CrCbGaD
Galantamine—Codeine—SLC22A1—hematologic cancer	0.000657	0.446	CrCbGaD
Galantamine—CYP3A4—hematopoietic system—hematologic cancer	0.000619	0.00578	CbGeAlD
Galantamine—CYP2D6—hematopoietic system—hematologic cancer	0.000609	0.00569	CbGeAlD
Galantamine—BCHE—blood—hematologic cancer	0.000609	0.00569	CbGeAlD
Galantamine—BCHE—bone marrow—hematologic cancer	0.000589	0.0055	CbGeAlD
Galantamine—BCHE—lung—hematologic cancer	0.000534	0.00498	CbGeAlD
Galantamine—BCHE—testis—hematologic cancer	0.000504	0.0047	CbGeAlD
Galantamine—CYP3A4—blood—hematologic cancer	0.00041	0.00383	CbGeAlD
Galantamine—CYP2D6—blood—hematologic cancer	0.000404	0.00377	CbGeAlD
Galantamine—BCHE—lymph node—hematologic cancer	0.000365	0.00341	CbGeAlD
Galantamine—CYP2D6—testis—hematologic cancer	0.000334	0.00312	CbGeAlD
Galantamine—Morphine—ABCB1—hematologic cancer	0.000155	0.105	CrCbGaD
Galantamine—Decreased appetite—Dexamethasone—hematologic cancer	3.63e-05	0.000105	CcSEcCtD
Galantamine—Decreased appetite—Betamethasone—hematologic cancer	3.63e-05	0.000105	CcSEcCtD
Galantamine—Nausea—Mitoxantrone—hematologic cancer	3.63e-05	0.000105	CcSEcCtD
Galantamine—Nausea—Irinotecan—hematologic cancer	3.63e-05	0.000105	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—hematologic cancer	3.62e-05	0.000105	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.61e-05	0.000105	CcSEcCtD
Galantamine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.61e-05	0.000105	CcSEcCtD
Galantamine—Back pain—Methotrexate—hematologic cancer	3.6e-05	0.000104	CcSEcCtD
Galantamine—Fatigue—Betamethasone—hematologic cancer	3.6e-05	0.000104	CcSEcCtD
Galantamine—Fatigue—Dexamethasone—hematologic cancer	3.6e-05	0.000104	CcSEcCtD
Galantamine—Shock—Prednisone—hematologic cancer	3.58e-05	0.000104	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—hematologic cancer	3.58e-05	0.000104	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—hematologic cancer	3.57e-05	0.000104	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—hematologic cancer	3.57e-05	0.000103	CcSEcCtD
Galantamine—Tachycardia—Prednisone—hematologic cancer	3.55e-05	0.000103	CcSEcCtD
Galantamine—Skin disorder—Prednisone—hematologic cancer	3.53e-05	0.000102	CcSEcCtD
Galantamine—Nausea—Gemcitabine—hematologic cancer	3.53e-05	0.000102	CcSEcCtD
Galantamine—Vomiting—Cisplatin—hematologic cancer	3.52e-05	0.000102	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—hematologic cancer	3.52e-05	0.000102	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—hematologic cancer	3.51e-05	0.000102	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—hematologic cancer	3.51e-05	0.000102	CcSEcCtD
Galantamine—Rash—Cisplatin—hematologic cancer	3.49e-05	0.000101	CcSEcCtD
Galantamine—Dermatitis—Cisplatin—hematologic cancer	3.49e-05	0.000101	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—hematologic cancer	3.49e-05	0.000101	CcSEcCtD
Galantamine—Diarrhoea—Etoposide—hematologic cancer	3.47e-05	0.000101	CcSEcCtD
Galantamine—Anorexia—Prednisone—hematologic cancer	3.47e-05	0.000101	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—hematologic cancer	3.46e-05	0.0001	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—hematologic cancer	3.46e-05	0.0001	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—hematologic cancer	3.46e-05	0.0001	CcSEcCtD
Galantamine—Anaemia—Methotrexate—hematologic cancer	3.44e-05	9.98e-05	CcSEcCtD
Galantamine—Feeling abnormal—Betamethasone—hematologic cancer	3.44e-05	9.98e-05	CcSEcCtD
Galantamine—Feeling abnormal—Dexamethasone—hematologic cancer	3.44e-05	9.98e-05	CcSEcCtD
Galantamine—Flushing—Doxorubicin—hematologic cancer	3.44e-05	9.97e-05	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—hematologic cancer	3.44e-05	9.97e-05	CcSEcCtD
Galantamine—Flatulence—Epirubicin—hematologic cancer	3.44e-05	9.96e-05	CcSEcCtD
Galantamine—Tension—Epirubicin—hematologic cancer	3.42e-05	9.92e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.42e-05	9.9e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.42e-05	9.9e-05	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—hematologic cancer	3.41e-05	9.9e-05	CcSEcCtD
Galantamine—Hypersensitivity—Triamcinolone—hematologic cancer	3.39e-05	9.83e-05	CcSEcCtD
Galantamine—Nervousness—Epirubicin—hematologic cancer	3.39e-05	9.82e-05	CcSEcCtD
Galantamine—Back pain—Epirubicin—hematologic cancer	3.37e-05	9.78e-05	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—hematologic cancer	3.36e-05	9.75e-05	CcSEcCtD
Galantamine—Malaise—Methotrexate—hematologic cancer	3.36e-05	9.74e-05	CcSEcCtD
Galantamine—Dizziness—Etoposide—hematologic cancer	3.36e-05	9.73e-05	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—hematologic cancer	3.35e-05	9.72e-05	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—hematologic cancer	3.35e-05	9.7e-05	CcSEcCtD
Galantamine—Vertigo—Methotrexate—hematologic cancer	3.35e-05	9.7e-05	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.32e-05	9.61e-05	CcSEcCtD
Galantamine—Dizziness—Prednisolone—hematologic cancer	3.31e-05	9.6e-05	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—hematologic cancer	3.31e-05	9.6e-05	CcSEcCtD
Galantamine—Asthenia—Triamcinolone—hematologic cancer	3.3e-05	9.58e-05	CcSEcCtD
Galantamine—Abdominal pain—Dexamethasone—hematologic cancer	3.3e-05	9.57e-05	CcSEcCtD
Galantamine—Body temperature increased—Dexamethasone—hematologic cancer	3.3e-05	9.57e-05	CcSEcCtD
Galantamine—Body temperature increased—Betamethasone—hematologic cancer	3.3e-05	9.57e-05	CcSEcCtD
Galantamine—Abdominal pain—Betamethasone—hematologic cancer	3.3e-05	9.57e-05	CcSEcCtD
Galantamine—Nausea—Cisplatin—hematologic cancer	3.29e-05	9.54e-05	CcSEcCtD
Galantamine—Insomnia—Prednisone—hematologic cancer	3.29e-05	9.54e-05	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—hematologic cancer	3.29e-05	9.53e-05	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—hematologic cancer	3.27e-05	9.47e-05	CcSEcCtD
Galantamine—Cough—Methotrexate—hematologic cancer	3.25e-05	9.42e-05	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—hematologic cancer	3.25e-05	9.41e-05	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—hematologic cancer	3.24e-05	9.38e-05	CcSEcCtD
Galantamine—Convulsion—Methotrexate—hematologic cancer	3.23e-05	9.36e-05	CcSEcCtD
Galantamine—Vomiting—Etoposide—hematologic cancer	3.23e-05	9.36e-05	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—hematologic cancer	3.23e-05	9.35e-05	CcSEcCtD
Galantamine—Anaemia—Epirubicin—hematologic cancer	3.22e-05	9.34e-05	CcSEcCtD
Galantamine—Agitation—Epirubicin—hematologic cancer	3.2e-05	9.29e-05	CcSEcCtD
Galantamine—Dyspepsia—Prednisone—hematologic cancer	3.2e-05	9.28e-05	CcSEcCtD
Galantamine—Rash—Etoposide—hematologic cancer	3.2e-05	9.28e-05	CcSEcCtD
Galantamine—Dermatitis—Etoposide—hematologic cancer	3.2e-05	9.27e-05	CcSEcCtD
Galantamine—Headache—Etoposide—hematologic cancer	3.18e-05	9.22e-05	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—hematologic cancer	3.18e-05	9.22e-05	CcSEcCtD
Galantamine—Chest pain—Methotrexate—hematologic cancer	3.17e-05	9.19e-05	CcSEcCtD
Galantamine—Myalgia—Methotrexate—hematologic cancer	3.17e-05	9.19e-05	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—hematologic cancer	3.17e-05	9.19e-05	CcSEcCtD
Galantamine—Tension—Doxorubicin—hematologic cancer	3.17e-05	9.18e-05	CcSEcCtD
Galantamine—Decreased appetite—Prednisone—hematologic cancer	3.16e-05	9.17e-05	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—hematologic cancer	3.16e-05	9.16e-05	CcSEcCtD
Galantamine—Rash—Prednisolone—hematologic cancer	3.16e-05	9.15e-05	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—hematologic cancer	3.15e-05	9.14e-05	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.15e-05	9.13e-05	CcSEcCtD
Galantamine—Malaise—Epirubicin—hematologic cancer	3.14e-05	9.11e-05	CcSEcCtD
Galantamine—Fatigue—Prednisone—hematologic cancer	3.14e-05	9.09e-05	CcSEcCtD
Galantamine—Headache—Prednisolone—hematologic cancer	3.14e-05	9.09e-05	CcSEcCtD
Galantamine—Discomfort—Methotrexate—hematologic cancer	3.13e-05	9.08e-05	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—hematologic cancer	3.13e-05	9.08e-05	CcSEcCtD
Galantamine—Vertigo—Epirubicin—hematologic cancer	3.13e-05	9.08e-05	CcSEcCtD
Galantamine—Syncope—Epirubicin—hematologic cancer	3.13e-05	9.06e-05	CcSEcCtD
Galantamine—Back pain—Doxorubicin—hematologic cancer	3.12e-05	9.05e-05	CcSEcCtD
Galantamine—Constipation—Prednisone—hematologic cancer	3.11e-05	9.02e-05	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—hematologic cancer	3.1e-05	8.99e-05	CcSEcCtD
Galantamine—Palpitations—Epirubicin—hematologic cancer	3.08e-05	8.93e-05	CcSEcCtD
Galantamine—Confusional state—Methotrexate—hematologic cancer	3.07e-05	8.89e-05	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—hematologic cancer	3.06e-05	8.88e-05	CcSEcCtD
Galantamine—Dizziness—Triamcinolone—hematologic cancer	3.05e-05	8.83e-05	CcSEcCtD
Galantamine—Cough—Epirubicin—hematologic cancer	3.04e-05	8.82e-05	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—hematologic cancer	3.04e-05	8.81e-05	CcSEcCtD
Galantamine—Convulsion—Epirubicin—hematologic cancer	3.02e-05	8.76e-05	CcSEcCtD
Galantamine—Nausea—Etoposide—hematologic cancer	3.02e-05	8.74e-05	CcSEcCtD
Galantamine—Hypertension—Epirubicin—hematologic cancer	3.01e-05	8.73e-05	CcSEcCtD
Galantamine—Feeling abnormal—Prednisone—hematologic cancer	3e-05	8.69e-05	CcSEcCtD
Galantamine—Asthenia—Dexamethasone—hematologic cancer	3e-05	8.69e-05	CcSEcCtD
Galantamine—Asthenia—Betamethasone—hematologic cancer	3e-05	8.69e-05	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.99e-05	8.68e-05	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—hematologic cancer	2.98e-05	8.64e-05	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—hematologic cancer	2.98e-05	8.64e-05	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—hematologic cancer	2.98e-05	8.63e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—hematologic cancer	2.98e-05	8.62e-05	CcSEcCtD
Galantamine—Nausea—Prednisolone—hematologic cancer	2.97e-05	8.62e-05	CcSEcCtD
Galantamine—Myalgia—Epirubicin—hematologic cancer	2.97e-05	8.6e-05	CcSEcCtD
Galantamine—Chest pain—Epirubicin—hematologic cancer	2.97e-05	8.6e-05	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—hematologic cancer	2.97e-05	8.6e-05	CcSEcCtD
Galantamine—Agitation—Doxorubicin—hematologic cancer	2.97e-05	8.59e-05	CcSEcCtD
Galantamine—Anxiety—Epirubicin—hematologic cancer	2.96e-05	8.58e-05	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—hematologic cancer	2.95e-05	8.56e-05	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.95e-05	8.55e-05	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—hematologic cancer	2.94e-05	8.52e-05	CcSEcCtD
Galantamine—Discomfort—Epirubicin—hematologic cancer	2.93e-05	8.5e-05	CcSEcCtD
Galantamine—Vomiting—Triamcinolone—hematologic cancer	2.93e-05	8.49e-05	CcSEcCtD
Galantamine—Malaise—Doxorubicin—hematologic cancer	2.91e-05	8.43e-05	CcSEcCtD
Galantamine—Rash—Triamcinolone—hematologic cancer	2.9e-05	8.42e-05	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—hematologic cancer	2.9e-05	8.42e-05	CcSEcCtD
Galantamine—Dermatitis—Triamcinolone—hematologic cancer	2.9e-05	8.41e-05	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—hematologic cancer	2.9e-05	8.4e-05	CcSEcCtD
Galantamine—Anorexia—Methotrexate—hematologic cancer	2.9e-05	8.4e-05	CcSEcCtD
Galantamine—Syncope—Doxorubicin—hematologic cancer	2.89e-05	8.39e-05	CcSEcCtD
Galantamine—Headache—Triamcinolone—hematologic cancer	2.88e-05	8.36e-05	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—hematologic cancer	2.88e-05	8.34e-05	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—hematologic cancer	2.88e-05	8.34e-05	CcSEcCtD
Galantamine—Confusional state—Epirubicin—hematologic cancer	2.87e-05	8.32e-05	CcSEcCtD
Galantamine—Diarrhoea—Dexamethasone—hematologic cancer	2.86e-05	8.29e-05	CcSEcCtD
Galantamine—Diarrhoea—Betamethasone—hematologic cancer	2.86e-05	8.29e-05	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—hematologic cancer	2.85e-05	8.26e-05	CcSEcCtD
Galantamine—Hypotension—Methotrexate—hematologic cancer	2.84e-05	8.24e-05	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—hematologic cancer	2.84e-05	8.22e-05	CcSEcCtD
Galantamine—Cough—Doxorubicin—hematologic cancer	2.82e-05	8.16e-05	CcSEcCtD
Galantamine—Shock—Epirubicin—hematologic cancer	2.8e-05	8.12e-05	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—hematologic cancer	2.8e-05	8.1e-05	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—hematologic cancer	2.79e-05	8.09e-05	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—hematologic cancer	2.79e-05	8.08e-05	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—hematologic cancer	2.79e-05	8.07e-05	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—hematologic cancer	2.78e-05	8.05e-05	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.77e-05	8.03e-05	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—hematologic cancer	2.76e-05	8.01e-05	CcSEcCtD
Galantamine—Dizziness—Dexamethasone—hematologic cancer	2.76e-05	8.01e-05	CcSEcCtD
Galantamine—Dizziness—Betamethasone—hematologic cancer	2.76e-05	8.01e-05	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—hematologic cancer	2.75e-05	7.97e-05	CcSEcCtD
Galantamine—Insomnia—Methotrexate—hematologic cancer	2.75e-05	7.97e-05	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—hematologic cancer	2.75e-05	7.96e-05	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—hematologic cancer	2.75e-05	7.96e-05	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—hematologic cancer	2.75e-05	7.96e-05	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—hematologic cancer	2.74e-05	7.93e-05	CcSEcCtD
Galantamine—Nausea—Triamcinolone—hematologic cancer	2.74e-05	7.93e-05	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—hematologic cancer	2.73e-05	7.91e-05	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.73e-05	7.91e-05	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—hematologic cancer	2.71e-05	7.87e-05	CcSEcCtD
Galantamine—Anorexia—Epirubicin—hematologic cancer	2.71e-05	7.86e-05	CcSEcCtD
Galantamine—Somnolence—Methotrexate—hematologic cancer	2.7e-05	7.84e-05	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—hematologic cancer	2.69e-05	7.79e-05	CcSEcCtD
Galantamine—Hypersensitivity—Prednisone—hematologic cancer	2.68e-05	7.77e-05	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—hematologic cancer	2.68e-05	7.76e-05	CcSEcCtD
Galantamine—Hypotension—Epirubicin—hematologic cancer	2.66e-05	7.71e-05	CcSEcCtD
Galantamine—Vomiting—Dexamethasone—hematologic cancer	2.66e-05	7.7e-05	CcSEcCtD
Galantamine—Vomiting—Betamethasone—hematologic cancer	2.66e-05	7.7e-05	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—hematologic cancer	2.66e-05	7.7e-05	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—hematologic cancer	2.64e-05	7.66e-05	CcSEcCtD
Galantamine—Rash—Betamethasone—hematologic cancer	2.63e-05	7.64e-05	CcSEcCtD
Galantamine—Rash—Dexamethasone—hematologic cancer	2.63e-05	7.64e-05	CcSEcCtD
Galantamine—Dermatitis—Betamethasone—hematologic cancer	2.63e-05	7.63e-05	CcSEcCtD
Galantamine—Dermatitis—Dexamethasone—hematologic cancer	2.63e-05	7.63e-05	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.63e-05	7.61e-05	CcSEcCtD
Galantamine—Fatigue—Methotrexate—hematologic cancer	2.62e-05	7.6e-05	CcSEcCtD
Galantamine—Headache—Dexamethasone—hematologic cancer	2.62e-05	7.59e-05	CcSEcCtD
Galantamine—Headache—Betamethasone—hematologic cancer	2.62e-05	7.59e-05	CcSEcCtD
Galantamine—Asthenia—Prednisone—hematologic cancer	2.61e-05	7.57e-05	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.59e-05	7.52e-05	CcSEcCtD
Galantamine—Shock—Doxorubicin—hematologic cancer	2.59e-05	7.51e-05	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—hematologic cancer	2.58e-05	7.48e-05	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.58e-05	7.47e-05	CcSEcCtD
Galantamine—Insomnia—Epirubicin—hematologic cancer	2.57e-05	7.46e-05	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—hematologic cancer	2.57e-05	7.45e-05	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—hematologic cancer	2.56e-05	7.41e-05	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—hematologic cancer	2.56e-05	7.41e-05	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.55e-05	7.38e-05	CcSEcCtD
Galantamine—Somnolence—Epirubicin—hematologic cancer	2.53e-05	7.33e-05	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—hematologic cancer	2.51e-05	7.28e-05	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—hematologic cancer	2.51e-05	7.26e-05	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—hematologic cancer	2.51e-05	7.26e-05	CcSEcCtD
Galantamine—Diarrhoea—Prednisone—hematologic cancer	2.49e-05	7.22e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.49e-05	7.21e-05	CcSEcCtD
Galantamine—Nausea—Dexamethasone—hematologic cancer	2.48e-05	7.19e-05	CcSEcCtD
Galantamine—Nausea—Betamethasone—hematologic cancer	2.48e-05	7.19e-05	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—hematologic cancer	2.47e-05	7.17e-05	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—hematologic cancer	2.46e-05	7.13e-05	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.46e-05	7.12e-05	CcSEcCtD
Galantamine—Fatigue—Epirubicin—hematologic cancer	2.45e-05	7.11e-05	CcSEcCtD
Galantamine—Constipation—Epirubicin—hematologic cancer	2.43e-05	7.05e-05	CcSEcCtD
Galantamine—Dizziness—Prednisone—hematologic cancer	2.41e-05	6.97e-05	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—hematologic cancer	2.4e-05	6.97e-05	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—hematologic cancer	2.4e-05	6.97e-05	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.4e-05	6.95e-05	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—hematologic cancer	2.38e-05	6.9e-05	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—hematologic cancer	2.36e-05	6.85e-05	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—hematologic cancer	2.35e-05	6.8e-05	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—hematologic cancer	2.34e-05	6.79e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.33e-05	6.75e-05	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—hematologic cancer	2.32e-05	6.72e-05	CcSEcCtD
Galantamine—Vomiting—Prednisone—hematologic cancer	2.31e-05	6.71e-05	CcSEcCtD
Galantamine—Rash—Prednisone—hematologic cancer	2.29e-05	6.65e-05	CcSEcCtD
Galantamine—Dermatitis—Prednisone—hematologic cancer	2.29e-05	6.64e-05	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—hematologic cancer	2.29e-05	6.63e-05	CcSEcCtD
Galantamine—Headache—Prednisone—hematologic cancer	2.28e-05	6.61e-05	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.27e-05	6.59e-05	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—hematologic cancer	2.27e-05	6.58e-05	CcSEcCtD
Galantamine—Constipation—Doxorubicin—hematologic cancer	2.25e-05	6.53e-05	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—hematologic cancer	2.25e-05	6.52e-05	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—hematologic cancer	2.25e-05	6.52e-05	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—hematologic cancer	2.24e-05	6.49e-05	CcSEcCtD
Galantamine—Asthenia—Methotrexate—hematologic cancer	2.18e-05	6.32e-05	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—hematologic cancer	2.17e-05	6.29e-05	CcSEcCtD
Galantamine—Nausea—Prednisone—hematologic cancer	2.16e-05	6.26e-05	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.15e-05	6.24e-05	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—hematologic cancer	2.1e-05	6.08e-05	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—hematologic cancer	2.08e-05	6.03e-05	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—hematologic cancer	2.08e-05	6.03e-05	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—hematologic cancer	2.08e-05	6.03e-05	CcSEcCtD
Galantamine—Asthenia—Epirubicin—hematologic cancer	2.04e-05	5.92e-05	CcSEcCtD
Galantamine—Dizziness—Methotrexate—hematologic cancer	2.01e-05	5.83e-05	CcSEcCtD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—hematologic cancer	2e-05	0.000196	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	1.99e-05	0.000196	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MDM2—hematologic cancer	1.99e-05	0.000195	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—hematologic cancer	1.98e-05	0.000194	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FHL2—hematologic cancer	1.96e-05	0.000192	CbGpPWpGaD
Galantamine—Diarrhoea—Epirubicin—hematologic cancer	1.95e-05	5.64e-05	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—hematologic cancer	1.94e-05	5.62e-05	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.93e-05	0.00019	CbGpPWpGaD
Galantamine—Vomiting—Methotrexate—hematologic cancer	1.93e-05	5.6e-05	CcSEcCtD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.92e-05	0.000189	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AGRN—hematologic cancer	1.92e-05	0.000188	CbGpPWpGaD
Galantamine—Rash—Methotrexate—hematologic cancer	1.92e-05	5.56e-05	CcSEcCtD
Galantamine—ACHE—Metabolism—ARNTL—hematologic cancer	1.92e-05	0.000188	CbGpPWpGaD
Galantamine—Dermatitis—Methotrexate—hematologic cancer	1.92e-05	5.55e-05	CcSEcCtD
Galantamine—Headache—Methotrexate—hematologic cancer	1.91e-05	5.52e-05	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—hematologic cancer	1.89e-05	5.48e-05	CcSEcCtD
Galantamine—Dizziness—Epirubicin—hematologic cancer	1.88e-05	5.45e-05	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.88e-05	0.000184	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.88e-05	0.000184	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—hematologic cancer	1.88e-05	0.000184	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA9—hematologic cancer	1.86e-05	0.000183	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ACP5—hematologic cancer	1.86e-05	0.000183	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—hematologic cancer	1.86e-05	0.000182	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	1.85e-05	0.000181	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOR2—hematologic cancer	1.84e-05	0.00018	CbGpPWpGaD
Galantamine—BCHE—Metabolism—IDH2—hematologic cancer	1.82e-05	0.000178	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMMR—hematologic cancer	1.82e-05	0.000178	CbGpPWpGaD
Galantamine—Vomiting—Epirubicin—hematologic cancer	1.81e-05	5.24e-05	CcSEcCtD
Galantamine—Nausea—Methotrexate—hematologic cancer	1.81e-05	5.24e-05	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—hematologic cancer	1.8e-05	5.22e-05	CcSEcCtD
Galantamine—Rash—Epirubicin—hematologic cancer	1.79e-05	5.2e-05	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—hematologic cancer	1.79e-05	5.2e-05	CcSEcCtD
Galantamine—Headache—Epirubicin—hematologic cancer	1.78e-05	5.17e-05	CcSEcCtD
Galantamine—BCHE—Neuronal System—MDM2—hematologic cancer	1.77e-05	0.000174	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—hematologic cancer	1.76e-05	0.000173	CbGpPWpGaD
Galantamine—ACHE—Metabolism—IDH1—hematologic cancer	1.75e-05	0.000172	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.75e-05	0.000172	CbGpPWpGaD
Galantamine—Dizziness—Doxorubicin—hematologic cancer	1.74e-05	5.05e-05	CcSEcCtD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.74e-05	0.00017	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTO1—hematologic cancer	1.73e-05	0.00017	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TXN—hematologic cancer	1.73e-05	0.00017	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCC3—hematologic cancer	1.73e-05	0.00017	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.71e-05	0.000168	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PHYH—hematologic cancer	1.71e-05	0.000168	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FTCD—hematologic cancer	1.71e-05	0.000168	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GMPS—hematologic cancer	1.71e-05	0.000168	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ARNTL—hematologic cancer	1.71e-05	0.000168	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SPHK1—hematologic cancer	1.7e-05	0.000166	CbGpPWpGaD
Galantamine—Nausea—Epirubicin—hematologic cancer	1.69e-05	4.9e-05	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—hematologic cancer	1.67e-05	4.85e-05	CcSEcCtD
Galantamine—BCHE—Metabolism—ACP5—hematologic cancer	1.66e-05	0.000163	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA9—hematologic cancer	1.66e-05	0.000163	CbGpPWpGaD
Galantamine—Rash—Doxorubicin—hematologic cancer	1.66e-05	4.81e-05	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—hematologic cancer	1.66e-05	4.81e-05	CcSEcCtD
Galantamine—Headache—Doxorubicin—hematologic cancer	1.65e-05	4.78e-05	CcSEcCtD
Galantamine—BCHE—Metabolism—NCOR2—hematologic cancer	1.64e-05	0.000161	CbGpPWpGaD
Galantamine—ACHE—Metabolism—UGT1A1—hematologic cancer	1.63e-05	0.00016	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.6e-05	0.000157	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC22A1—hematologic cancer	1.59e-05	0.000155	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CRABP1—hematologic cancer	1.59e-05	0.000155	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SMPD3—hematologic cancer	1.57e-05	0.000154	CbGpPWpGaD
Galantamine—Nausea—Doxorubicin—hematologic cancer	1.56e-05	4.53e-05	CcSEcCtD
Galantamine—BCHE—Metabolism—IDH1—hematologic cancer	1.56e-05	0.000153	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TXN—hematologic cancer	1.55e-05	0.000152	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCC3—hematologic cancer	1.55e-05	0.000152	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTO1—hematologic cancer	1.55e-05	0.000152	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5—hematologic cancer	1.54e-05	0.000152	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.54e-05	0.000151	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—hematologic cancer	1.53e-05	0.00015	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SPHK1—hematologic cancer	1.51e-05	0.000148	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NUP98—hematologic cancer	1.5e-05	0.000147	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.46e-05	0.000143	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UGT1A1—hematologic cancer	1.45e-05	0.000143	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADCY7—hematologic cancer	1.45e-05	0.000142	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOA3—hematologic cancer	1.45e-05	0.000142	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NUP214—hematologic cancer	1.44e-05	0.000141	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.44e-05	0.000141	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.43e-05	0.00014	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.42e-05	0.00014	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC22A1—hematologic cancer	1.41e-05	0.000139	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CRABP1—hematologic cancer	1.41e-05	0.000139	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTR—hematologic cancer	1.41e-05	0.000139	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCG2—hematologic cancer	1.41e-05	0.000139	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ENO2—hematologic cancer	1.39e-05	0.000136	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5—hematologic cancer	1.38e-05	0.000135	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.37e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DCK—hematologic cancer	1.37e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ASNS—hematologic cancer	1.37e-05	0.000134	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—hematologic cancer	1.34e-05	0.000132	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.34e-05	0.000132	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NUP98—hematologic cancer	1.33e-05	0.000131	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.32e-05	0.00013	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.32e-05	0.00013	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SDC1—hematologic cancer	1.31e-05	0.000129	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.3e-05	0.000128	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HDC—hematologic cancer	1.3e-05	0.000127	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADCY7—hematologic cancer	1.3e-05	0.000127	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOA3—hematologic cancer	1.3e-05	0.000127	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NUP214—hematologic cancer	1.29e-05	0.000126	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.27e-05	0.000125	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.27e-05	0.000125	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCG2—hematologic cancer	1.26e-05	0.000124	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTR—hematologic cancer	1.26e-05	0.000124	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.25e-05	0.000123	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.24e-05	0.000121	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ENO2—hematologic cancer	1.24e-05	0.000121	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—hematologic cancer	1.2e-05	0.000118	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CDA—hematologic cancer	1.19e-05	0.000116	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.18e-05	0.000116	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.18e-05	0.000116	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SDC1—hematologic cancer	1.17e-05	0.000115	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CCL2—hematologic cancer	1.15e-05	0.000113	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PC—hematologic cancer	1.14e-05	0.000112	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NQO1—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CD44—hematologic cancer	1.12e-05	0.00011	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.1e-05	0.000108	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GBA—hematologic cancer	1.1e-05	0.000108	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.1e-05	0.000108	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.09e-05	0.000107	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—hematologic cancer	1.09e-05	0.000107	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.06e-05	0.000104	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYCS—hematologic cancer	1.06e-05	0.000104	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSP90AA1—hematologic cancer	1.05e-05	0.000103	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CCL2—hematologic cancer	1.02e-05	0.000101	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.02e-05	0.0001	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.01e-05	9.9e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CD44—hematologic cancer	9.96e-06	9.77e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NQO1—hematologic cancer	9.96e-06	9.77e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.76e-06	9.57e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—hematologic cancer	9.73e-06	9.55e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.45e-06	9.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYCS—hematologic cancer	9.43e-06	9.25e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSP90AA1—hematologic cancer	9.37e-06	9.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—hematologic cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.01e-06	8.84e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FHL2—hematologic cancer	8.99e-06	8.82e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DCK—hematologic cancer	8.95e-06	8.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.95e-06	8.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ASNS—hematologic cancer	8.95e-06	8.78e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AGRN—hematologic cancer	8.82e-06	8.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—hematologic cancer	8.82e-06	8.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOR1—hematologic cancer	8.56e-06	8.4e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—hematologic cancer	8.56e-06	8.4e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HDC—hematologic cancer	8.48e-06	8.32e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.43e-06	8.27e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH2—hematologic cancer	8.36e-06	8.2e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMMR—hematologic cancer	8.36e-06	8.2e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—hematologic cancer	8.31e-06	8.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.04e-06	7.89e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—hematologic cancer	7.87e-06	7.72e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ARNTL—hematologic cancer	7.86e-06	7.71e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CDA—hematologic cancer	7.76e-06	7.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACP5—hematologic cancer	7.65e-06	7.5e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA9—hematologic cancer	7.65e-06	7.5e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—hematologic cancer	7.64e-06	7.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOR1—hematologic cancer	7.64e-06	7.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—hematologic cancer	7.57e-06	7.42e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOR2—hematologic cancer	7.55e-06	7.4e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PC—hematologic cancer	7.47e-06	7.33e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GBA—hematologic cancer	7.21e-06	7.07e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.21e-06	7.07e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH1—hematologic cancer	7.19e-06	7.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.11e-06	6.97e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.11e-06	6.97e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TXN—hematologic cancer	7.11e-06	6.97e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SPHK1—hematologic cancer	6.96e-06	6.82e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—hematologic cancer	6.75e-06	6.62e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	6.68e-06	6.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.67e-06	6.54e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTAP—hematologic cancer	6.6e-06	6.47e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	6.5e-06	6.38e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CRABP1—hematologic cancer	6.5e-06	6.38e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—hematologic cancer	6.36e-06	6.23e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.34e-06	6.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NUP98—hematologic cancer	6.14e-06	6.02e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.96e-06	5.84e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.96e-06	5.84e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.95e-06	5.83e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NUP214—hematologic cancer	5.92e-06	5.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CREBBP—hematologic cancer	5.89e-06	5.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.88e-06	5.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.8e-06	5.68e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTR—hematologic cancer	5.8e-06	5.68e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AGRN—hematologic cancer	5.77e-06	5.66e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO2—hematologic cancer	5.68e-06	5.57e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—hematologic cancer	5.67e-06	5.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—hematologic cancer	5.59e-06	5.48e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—hematologic cancer	5.52e-06	5.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.51e-06	5.41e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH2—hematologic cancer	5.47e-06	5.36e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMMR—hematologic cancer	5.47e-06	5.36e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.39e-06	5.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3R1—hematologic cancer	5.28e-06	5.18e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CREBBP—hematologic cancer	5.26e-06	5.16e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.14e-06	5.04e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACP5—hematologic cancer	5e-06	4.9e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA9—hematologic cancer	5e-06	4.9e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—hematologic cancer	4.98e-06	4.89e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.93e-06	4.84e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—hematologic cancer	4.92e-06	4.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—hematologic cancer	4.87e-06	4.78e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3R1—hematologic cancer	4.71e-06	4.62e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.7e-06	4.61e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TXN—hematologic cancer	4.65e-06	4.56e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.65e-06	4.56e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.65e-06	4.56e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CD44—hematologic cancer	4.58e-06	4.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.58e-06	4.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.55e-06	4.46e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.37e-06	4.29e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—hematologic cancer	4.34e-06	4.26e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.33e-06	4.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.31e-06	4.22e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.25e-06	4.17e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.25e-06	4.17e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—hematologic cancer	4.21e-06	4.13e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.14e-06	4.06e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—EP300—hematologic cancer	4.01e-06	3.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.01e-06	3.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.89e-06	3.82e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.89e-06	3.82e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.87e-06	3.79e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.82e-06	3.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTR—hematologic cancer	3.79e-06	3.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.79e-06	3.72e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—hematologic cancer	3.75e-06	3.68e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.72e-06	3.64e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.62e-06	3.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.6e-06	3.54e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EP300—hematologic cancer	3.58e-06	3.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.52e-06	3.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.51e-06	3.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.51e-06	3.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.1e-06	3.04e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CD44—hematologic cancer	3e-06	2.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NQO1—hematologic cancer	3e-06	2.94e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—hematologic cancer	2.97e-06	2.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.83e-06	2.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.82e-06	2.76e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—hematologic cancer	2.65e-06	2.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.61e-06	2.56e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.5e-06	2.45e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—hematologic cancer	2.43e-06	2.38e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.42e-06	2.37e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.36e-06	2.32e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.3e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.3e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.29e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—hematologic cancer	2.26e-06	2.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.16e-06	2.12e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—hematologic cancer	2.16e-06	2.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.03e-06	1.99e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2e-06	1.96e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.73e-06	1.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.7e-06	1.67e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EP300—hematologic cancer	1.65e-06	1.61e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.58e-06	1.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.5e-06	1.47e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—hematologic cancer	1.48e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.31e-06	1.28e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.13e-06	1.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EP300—hematologic cancer	1.08e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—hematologic cancer	9.95e-07	9.76e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.96e-07	7.81e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—hematologic cancer	6.5e-07	6.38e-06	CbGpPWpGaD
